Teewinot Life Sciences Corporation is an international biopharmaceutical company focused on advanced pharmaceutical research and the use of novel biosynthetic processes such as biocatalysis and synthetic biology for cannabinoid manufacture. Coupled with patented formulation technologies, Teewinot is a leader in the production and delivery of cannabinoid-based therapies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/02/17 | $12,300,000 | Series B |
Tuatara Capital | undisclosed |
